Normalizing mitochondrial calcium by inhibiting MCU in HepG2 cells attenuated HG-induced insulin resistance and inflammation by mechanisms involving the inhibition of ROS production and decreasing the activity of the MAPKs and NF-κB signaling pathways. This evidence concerns the gene NFKB1 and Insulin resistance.